Skip to content
drillr.ai
Sign up

01548.HK

Genscript Biotech Corporation

HKSE · Healthcare · Biotechnology · CN

HKD 39.34
+5.70%
Ask drillr

  • Sep 18, 2026, 08:12 UTC

    Hong Kong stocks closed higher on September 18, 2026, with the Hang Seng Index up 146 points (0.6%) at 24,750 and the Hang Seng Tech Index up 94 points (2.2%) at 4,405, as Alibaba rose over 3% and Lenovo Group, Liuliumei, Lenovo Holdings, Yingsheng Holdings and GenScript Biotech hit record highs.

    Source:

  • Sep 18, 2026, 03:31 UTC

    Genscript Biotech shares extended gains to a five-year high.

    Source:

  • Sep 18, 2026, 01:56 UTC

    Hong Kong's three main stock indices opened higher, with the Hang Seng Index up 0.49%, the China Enterprises Index up 0.34%, and the Hang Seng Tech Index up 0.41%, as semiconductor and tech shares rebounded.

    Source:

  • Sep 17, 2026, 13:36 UTC

    Bestzyme Bio, a subsidiary of GenScript Biotech, completed construction of an automated smart production line for sweet proteins in Jinan, China, the world's first commercial line dedicated to sweet protein production.

    Source:

  • Sep 17, 2026, 08:12 UTC

    Hong Kong's Hang Seng Index closed down 109 points, or 0.4%, at 24,604 on September 17, 2026, with the Hang Seng Tech Index falling 14 points to 4,310.

    Source:

  • Sep 17, 2026, 04:12 UTC

    Hong Kong stocks fell in the morning session on September 17, 2026, with the Hang Seng Index down 180 points to 24,533 and the Hang Seng Tech Index down 32 points to 4,292.

    Source:

  • Sep 17, 2026, 02:03 UTC

    GenScript Biotech announced a collaboration with Eli Lilly's AI/machine-learning drug discovery platform Lilly TuneLab, under which GenScript will provide wet-lab services to Lilly TuneLab participating companies.

    Source:

  • Sep 10, 2026, 12:49 UTC

    GenScript Biotech (01548.HK) plans to place new shares at HK$30.08-30.5 per share to raise about US$300 million (about HK$2.34 billion), a 4.7-6% discount to Thursday's HK$32 close, with JPMorgan as placing agent and a 90-day lock-up.

    Source:

  • Aug 20, 2026, 01:46 UTC

    On August 20, 2026, Hong Kong-listed biotech stocks surged broadly, with 3D Medicines rising 55%, Everest Medicines rising 50%, CanSino Biologics rising 45%, and other biotech firms gaining sharply.

    Source:

  • Aug 16, 2026, 10:42 UTC

    GenScript Biotech announced its first-half results, with adjusted net profit up 203.3% year-on-year and revenue up 27.3% year-on-year.

    Source:

  • Aug 13, 2026, 04:12 UTC

    GenScript Biotech Corporation rose 6% to HK$26.36, hitting a new high.

    Source: